Acromegaly Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Acromegaly Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Acromegaly Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Acromegaly, historical and forecasted epidemiology as well as the Acromegaly market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Acromegaly is a rare but serious condition caused by too much growth hormone (GH) in the blood. GH is released into the bloodstream by the pituitary gland, located at the base of the brain. The blood carries GH to other parts of the body where it has specific effects. In children, GH stimulates growth and development. In adults, GH affects energy levels, muscle strength, bone health, and one’s sense of well-being. Too much GH in children is called gigantism and is extremely rare.

As per the DelveInsight, the Acromegaly market is expected to grow by factors like an increase in the prevalent pool, expected entry of emerging therapies with novel targets and attractive pricing, expected launch of Octreotide capsules, and more penetration in the 7MM markets.

Get FREE sample copy at:

The Acromegaly market report also covers emerging drugs, current treatment practices, Acromegaly market share of the individual therapies, current and forecasted Acromegaly Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Acromegaly treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Acromegaly Market Key Facts

  • As per DelveInsight analysis, there was a total of 64,508 Acromegaly prevalent cases in 2017, and diagnosed patient pool comprised of 49,814 patients.

  • In the case of the United States, the prevalent population was estimated to be 28,671 cases in 2017.

  • The diagnosed cases of Acromegaly based on types of Adenomas were 18,349 of macroadenomas and 4,587 of microadenomas in 2017, in the US.

  • In the EU5, the highest prevalent cases were reported to be in Germany followed by the United Kingdom and France whereas the lowest prevalence rates were reported in Spain.

Acromegaly Market

Key Benefits of Acromegaly Market Report

  • Acromegaly market report provides an in-depth analysis of Acromegaly Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Acromegaly market report will help in developing business strategies by understanding the Acromegaly Market trends & developments, key players, and future market competition that will shape and drive the Acromegaly market in the upcoming years.

  • The Acromegaly market report covers Acromegaly current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Acromegaly market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Acromegaly Market

As per the DelveInsight, the Acromegaly market size was found to be USD 956.96 Million in 2017 in the 7MM. Acromegaly market size is anticipated to increase during the study period owing to the increasing prevalent population of Acromegaly in the 7MM.

The Acromegaly market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Acromegaly market trends by analysing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Acromegaly market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Acromegaly Epidemiology

The Acromegaly epidemiology section covers insights about the historical and current Acromegaly patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Acromegaly Drugs Uptake and Key Market Players

The Acromegaly Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acromegaly market or expected to get launched in the market during the study period. The analysis covers Acromegaly market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Acromegaly Companies:
Chiasma Pharma
Ionis Pharmaceuticals
Antisense Therapeutics
Strongbridge Biopharma
Crinetics Pharmaceuticals
And many others.

Acromegaly Therapies covered in the report include:
Octreotide Capsules
Lanreotide PRF
And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Acromegaly Competitive Intelligence Analysis

4. Acromegaly Market Overview at a Glance

5. Acromegaly Disease Background and Overview

6. Acromegaly Patient Journey

7. Acromegaly Epidemiology and Patient Population

8. Acromegaly Treatment Algorithm, Current Treatment, and Medical Practices

9. Acromegaly Unmet Needs

10. Key Endpoints of Acromegaly Treatment

11. Acromegaly Marketed Products

12. Acromegaly Emerging Therapies

13. Acromegaly Seven Major Market Analysis

14. Attribute Analysis

15. Acromegaly Market Outlook (7 major markets)

16. Acromegaly Access and Reimbursement Overview

17. KOL Views on the Acromegaly Market.

18. Acromegaly Market Drivers

19. Acromegaly Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer
*The table of contents is not exhaustive; the final content may vary. 

Latest Healthcare Reports By DelveInsight
Acromegaly Pipeline Insights
Acromegaly Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acromegaly market.

Neurovascular Thrombectomy Devices Market
DelveInsight’s “Neurovascular Thrombectomy Devices Market Insights, Competitive Landscape and Market Forecast–2026” report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States